Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease
Neuroradiology · 2025
DOI: 10.1007/s00234-024-03516-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroradiology, 2025. Verfasst von Roland Opfer und 10 weiteren Autor:innen. Beteiligte Einrichtung: jung diagnostics GmbH, Hamburg, Germany. roland.opfer@jung-diagnostics.de. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Thalamus, Magnetic Resonance Imaging, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Bristol Myers Squibb Foundation.
Abstract (Originalsprache)
BACKGROUND: The aim of this study was to investigate the dynamics of annual whole brain volume loss (BVL/year) and annual thalamic volume loss (ThalaVL/year) in patients with relapsing-remitting multiple sclerosis (PwRRMS) during the course of the disease. METHODS: A longitudinal database of magnetic resonance imaging (MRI) scans of 195 healthy individuals (age range, 22.8-63.7 years) and longitudinal MRI data of 256 PwRRMS (age range, 20.1-60.8 years) were analyzed and compared. BVL/year and ThalaVL/year were computed for healthy individuals as well as for all patients with MS using a Jacobian integration approach. A linear regression was used to compute the relationship between age and BVL/year and ThalaVL/year for healthy individuals. The linear regression was then used to decompose the BVL/year and ThalaVL/year into a multiple sclerosis (MS)-related and an age-related component for each PwRRMS. PwRRMS were dichotomized into early-phase RRMS (disease duration ≤ 6 years) and later-phase RRMS (disease duration > 6 years), and a t-test was performed to test for differences between these groups. RESULTS: The 135 early-phase patients (disease duration, ≤ 6 years) had statistically significantly higher MS-related BVL/year than the later-phase patients (n = 121) (- 0.21% vs. - 0.06%, p = 0.007). For MS-related ThalaVL/year, the difference between the groups was even more pronounced (- 0.39% vs. - 0.00%, p < 0.0001). CONCLUSIONS: Our results indicate that in PwRRMS, the MS-related components of BVL/year and ThalaVL/year are accelerated in early phases and slowdown in later phases of the disease. This might explain why early intervention often leads to improved outcomes in patients with MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- jung diagnostics GmbH, Hamburg, Germany. roland.opfer@jung-diagnostics.de.
- Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.
- Bristol Myers Squibb, Princeton, NJ, USA.
- jung diagnostics GmbH, Hamburg, Germany.
- Conradia Medical Prevention Hamburg, Hamburg, Germany.
- Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Förderung
- Bristol Myers Squibb Foundation
Zitieren
APA
Opfer, R., Schwab, M., Bangoura, S., Biswas, M., Krüger, J., Spies, L., Gocke, C., Gaser, C., Schippling, S., Kitzler, H. H., & Ziemssen, T. (2025). Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease. Neuroradiology. https://doi.org/10.1007/s00234-024-03516-7
Vancouver
Opfer R, Schwab M, Bangoura S, Biswas M, Krüger J, Spies L, et al. Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease. Neuroradiology. 2025. doi:10.1007/s00234-024-03516-7
BibTeX
@article{Opfer2025,
author = {Opfer, Roland and Schwab, Matthias and Bangoura, Sabine and Biswas, Mousumi and Krüger, Julia and Spies, Lothar and Gocke, Carola and Gaser, Christian and Schippling, Sven and Kitzler, Hagen H and Ziemssen, Tjalf},
title = {Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease},
journal = {Neuroradiology},
year = {2025},
doi = {10.1007/s00234-024-03516-7}
}
EUVIMED